Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

J M Kyriakis1, J Avruch

  • 1Diabetes Research Laboratory, Medical Services, Massachusetts General Hospital, Boston, Massachusetts 02129, USA. kyriakis@helix.mgh.harvard.edu

Physiological Reviews
|March 29, 2001
PubMed

Insights

Mammalian stress-activated signal transduction pathways, particularly mitogen-activated protein kinase (MAPK) pathways, are crucial for health and disease. Understanding these complex signaling networks offers potential for developing novel therapeutic strategies.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Stress-activated signal transduction pathways profoundly impact numerous physiological processes and diseases.
  • Cardiovascular disease and diabetes mellitus are major global health concerns linked to these pathways.
  • Recent advancements have significantly improved our understanding of these critical biological networks.

Purpose of the Study:

  • To review the biochemical components and regulation of mammalian stress-regulated mitogen-activated protein kinase (MAPK) pathways.
  • To highlight the progress made in dissecting these pathways over the past decade.
  • To bridge the gap between fundamental research and potential therapeutic applications.

Main Methods:

  • Literature review focusing on stress-regulated MAPK pathways.
  • Analysis of biochemical components and regulatory mechanisms.
  • Synthesis of recent findings in the field.

Main Results:

  • Detailed examination of the molecular intricacies of mammalian stress-activated MAPK pathways.
  • Identification of key regulatory elements within these signaling cascades.
  • Discussion of the profound implications for various pathologies and physiological functions.

Conclusions:

  • Significant progress has been made in understanding stress-regulated MAPK pathways.
  • These pathways are integral to conditions such as inflammation, heart disease, diabetes, and immune responses.
  • Findings pave the way for the development of novel treatment strategies targeting these signaling networks.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...